This script search US Code. View Rule
Menu Item - Home
Menu Item - Agenda Main page
Menu Item - Historical Agenda
Menu Item - Historical Agenda
Menu Item - Agenda Search
Menu Item - Agenda XML Reports
Menu Item - EO Dashboard
Menu Item - Reg Review
Menu Item - EO Agency lists
Menu Item - EO Search
Menu Item - EO Historical Reports
Menu Item - Review Counts
Menu Item - OIRA Letters
Menu Item - EOM 12866 Search
Menu Item - EO XML Reports
Menu Item - ICR Dashboard page
Menu Item - ICR Main page
Menu Item - ICR Search
Menu Item - ICR XML Reports
Menu Item - FAQ
Menu Item - Additional Resources
Menu Item - Contact Us
Search: Agenda Reg Review ICR

View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/FDA RIN: 0910-AF46 Publication ID: Spring 2008 
Title: Substances Prohibited From Use in Animal Food or Feed To Prevent the Transmission of Bovine Spongiform Encephalopathy 
Abstract: On October 6, 2005, the Food and Drug Administration (FDA) proposed to amend its regulations to prohibit the use of certain cattle origin materials in the food or feed of all animals to help strengthen existing safeguards to prevent the spread of bovine spongiform encephalopathy (BSE) in U.S. cattle. The discovery of a BSE-positive dairy cow in December 2003 has caused FDA to review its policies for prevention of BSE, which resulted in this rulemaking. 
Agency: Department of Health and Human Services(HHS)  Priority: Economically Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: Yes  Unfunded Mandates: No 
CFR Citation: 21 CFR 589.2001   
Legal Authority: 21 USC 321    21 USC 342    21 USC 343    21 USC 348    21 USC 371   
Legal Deadline:  None
Action Date FR Cite
ANPRM  07/14/2004  69 FR 42288   
ANPRM Comment Period End  08/13/2004    
NPRM  10/06/2005  70 FR 58569   
NPRM Comment Period End  12/20/2005    
Final Rule  04/25/2008  73 FR 22720   
Final Rule-Correction  06/00/2008    
Final Rule Effective  04/27/2009    
Regulatory Flexibility Analysis Required: Yes  Government Levels Affected: None 
Small Entities Affected: Businesses  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: Yes 
Agency Contact:
Burt Pritchett
Department of Health and Human Services
Food and Drug Administration
Center for Veterinary Medicine, Room 2654 (MPN-4, HFV-222), 7519 Standish Place,
Rockville, MD 20855
Phone:240 453-6860
Fax:240 453-6882

About Us   Vertical Spacer Spacer Related Resources   Vertical Spacer Spacer Disclosure   Vertical Spacer Spacer Accessibility   Vertical Spacer Spacer Privacy Policy   Vertical Spacer Spacer Contact Us